These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology. Catalona WJ; Chretien PB Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881 [No Abstract] [Full Text] [Related]
7. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer. Lee YT; Sparks FC; Eilber FR; Morton DL Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942 [TBL] [Abstract][Full Text] [Related]
8. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients. Bolton PM Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933 [No Abstract] [Full Text] [Related]
9. Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer. Thornes RD Lancet; 1974 Aug; 2(7877):382-4. PubMed ID: 4137344 [No Abstract] [Full Text] [Related]
10. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Chretien PB; Crowder WL; Gertner HR; Sample WF; Catalona WJ Surg Gynecol Obstet; 1973 Mar; 136(3):380-4. PubMed ID: 4688801 [No Abstract] [Full Text] [Related]
11. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Catalona WJ; Sample WF; Chretien PB Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045 [No Abstract] [Full Text] [Related]
12. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials. Browder JP; Chretien PB Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354 [No Abstract] [Full Text] [Related]
13. Cellular and humoral immunity to different types of human neoplasms. Hellström I; Hellström KE; Pierce GE; Yang JP Nature; 1968 Dec; 220(5174):1352-4. PubMed ID: 4302696 [No Abstract] [Full Text] [Related]
14. Abnormal monocyte chemotactic response in cancer patients. Boetcher DA; Leonard EJ J Natl Cancer Inst; 1974 Apr; 52(4):1091-9. PubMed ID: 4826580 [No Abstract] [Full Text] [Related]
15. Delayed hypersensitivity in patients with bronchial carcinoma. Pauwels R; van der Straeten M Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307 [TBL] [Abstract][Full Text] [Related]
16. [Immunosuppression: a paraneoplastic syndrome]. Nagel GA Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773 [No Abstract] [Full Text] [Related]
17. Immunologic defects in lung cancer patients. Holmes EC; Golub SH J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678 [TBL] [Abstract][Full Text] [Related]
18. Thymus-derived lymphocytes in patients with solid malignancies. Potvin C; Tarpley JL; Chretien B Clin Immunol Immunopathol; 1975 Mar; 3(4):476-81. PubMed ID: 1078796 [No Abstract] [Full Text] [Related]
19. BCG in cancer therapy: theoretical bases of immunotherapy. Dodd MJ Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587 [No Abstract] [Full Text] [Related]
20. Pulmonary embolism during anesthesia: a case report and review of literature. Gotta AW; Sullivan CA Anesth Analg; 1970; 49(1):73-8. PubMed ID: 5461072 [No Abstract] [Full Text] [Related] [Next] [New Search]